Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Barnett

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Oncology|July 9, 2009
Lenalidomide for the treatment of relapsed multiple myelomaElangovan Gajraj, Helen Chung, Meindert Boysen, et al.
BMJ (Clinical Research Ed.)|October 7, 2006
Poor prescribing is continualJeffrey K Aronson, David B Barnett, Robin E Ferner, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Oncology|July 9, 2009
Lenalidomide for the treatment of relapsed multiple myelomaElangovan Gajraj, Helen Chung, Meindert Boysen, et al.
BMJ (Clinical Research Ed.)|October 7, 2006
Poor prescribing is continualJeffrey K Aronson, David B Barnett, Robin E Ferner, et al.
Lancet (London, England)|April 14, 2009
The UK's NHS and pharma: need for more clinical pharmacologistsJeffrey K Aronson, David B Barnett, Alasdair M Breckenridge, et al.
Pageof 1